<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03027349</url>
  </required_header>
  <id_info>
    <org_study_id>Primary hyperparathyroidism</org_study_id>
    <nct_id>NCT03027349</nct_id>
  </id_info>
  <brief_title>Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda USL Modena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda USL Modena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Primary hyperparathyroidism (PHPT) is often overlooked and underdiagnosed. At present the&#xD;
      diagnosis of PHPT remains challenging and is based on serum calcium (Ca) and PTH.&#xD;
&#xD;
      As serum Ca and phosphorous (P) are inversely related in PHPT, the Ca/P ratio might be&#xD;
      considered a good candidate tool in the diagnosis of PHPT.&#xD;
&#xD;
      AIM: The aim of this study is to investigate the diagnostic value of the Ca/P ratio in the&#xD;
      diagnosis of PHPT.&#xD;
&#xD;
      Study design: Retrospective, observational, cross-sectional, case-control clinical trial will&#xD;
      be carried out.&#xD;
&#xD;
      Biochemical measurements will include PTH, Vitamin D, serum Ca, P, albumin, and creatinine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Calcium</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phosphorus</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parathormone</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumine</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>Enrollment time</time_frame>
    <description>Assay performed at the moment of diagnosis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Patients aged between 18-90 years old with primary hyperparathyroidism who had been diagnosed in the Unit of Endocrinology of the University of Modena and Reggio Emilia.&#xD;
The exclusion criteria will be:&#xD;
age younger than 18 years&#xD;
renal and liver failure and insufficiency&#xD;
active metabolic bone disease (such as Paget's disease of the bone, osteomalacia, rickets, etc)&#xD;
any type of cancer&#xD;
malnutrition, severe obesity (BMI &gt; 40 kg/m2) and malabsorption&#xD;
transplantation&#xD;
sarcoidosis&#xD;
endocrinological disorders such as hypercortisolism, diabetes insipidus, hyperthyroidism, pseudohypoparathyroidism&#xD;
familial hypocalciuric hypercalcemia&#xD;
hypophosphoremia sustained by genetic causes or secondary to other causes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients that underwent biochemical examination by primary care physician or by endocrinologist in order to assess their parathyroid function and calcium metabolism state with results into the normal ranges.&#xD;
The exclusion criteria will be:&#xD;
age younger than 18 years&#xD;
renal and liver failure and insufficiency&#xD;
active metabolic bone disease (such as Paget's disease of the bone, osteomalacia, rickets, etc)&#xD;
any type of cancer&#xD;
malnutrition, severe obesity (BMI &gt; 40 kg/m2) and malabsorption&#xD;
transplantation&#xD;
sarcoidosis&#xD;
endocrinological disorders such as hypercortisolism, diabetes insipidus, hyperthyroidism, pseudohypoparathyroidism&#xD;
familial hypocalciuric hypercalcemia&#xD;
hypophosphoremia sustained by genetic causes or secondary to other causes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention are provided</intervention_name>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosis of primary hyperparathyroidism&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  elevated parathormone serum levels&#xD;
&#xD;
          -  normal or elevated calcium serum levels&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 18 years&#xD;
&#xD;
          -  renal and liver failure and insufficiency&#xD;
&#xD;
          -  active metabolic bone disease (such as Paget's disease of the bone, osteomalacia,&#xD;
             rickets, etc)&#xD;
&#xD;
          -  any type of cancer&#xD;
&#xD;
          -  malnutrition, severe obesity (BMI &gt; 40 kg/m2) and malabsorption&#xD;
&#xD;
          -  transplantation&#xD;
&#xD;
          -  sarcoidosis&#xD;
&#xD;
          -  endocrinological disorders such as hypercortisolism, diabetes insipidus,&#xD;
             hyperthyroidism, pseudohypoparathyroidism&#xD;
&#xD;
          -  familial hypocalciuric hypercalcemia&#xD;
&#xD;
          -  hypophosphoremia sustained by genetic causes or secondary to other causes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda USL of Modena</name>
      <address>
        <city>Modena</city>
        <zip>41126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>January 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2017</study_first_posted>
  <last_update_submitted>February 14, 2017</last_update_submitted>
  <last_update_submitted_qc>February 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda USL Modena</investigator_affiliation>
    <investigator_full_name>Manuela Simoni</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

